Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regeneration of Articular Cartilage in Grade II, III and IV Knee Osteoarthritis by Intraarticular Injection of Autologous Bone Marrow Stem Cells Expanded ex Vivo With a GMP Procedure Developed by IBGM-Valladolid (MSV)

NCT01183728 is registered in ClinicalTrials.gov with Red de Terapia Celular as lead sponsor.

NCT NCT01183728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01183728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regeneration of Articular Cartilage in Grade II, III and IV Knee Osteoarthritis by Intraarticular Injection of Autologous Bone Marrow Stem Cells Expanded ex Vivo With a GMP Procedure Developed by IBGM-Valladolid (MSV)
Lead sponsor
Red de Terapia Celular
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2010
Completion date
September 30, 2014
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

knee degenerative disease, knee osteoarthritis, osteoarthritis, knee